OPTIMIZATION OF TISSUE-SELECTIVE ABCA1 AGONISTS (TSAAGS) AS AN EFFECTIVE AND TOLERATED THERAPY FOR ALZHEIMER’S DISEASE

Autor: Ben Aissa, Manel, Lee, Sue H., Lewandowski, Cutler T., LaDu, Mary Jo, Thatcher, Gregory R.
Zdroj: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P1658-P1658
Databáze: ScienceDirect